Amarin (AMRN) Affirms Receiving Patent '598 for AMR101
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Join SI Premium – FREE
Amarin Corporation plc (Nasdaq: AMRN), reports that the United States Patent and Trademark Office (USPTO) has published notification of a Notice of Allowance for U.S. Patent Application Serial Number 12/052,598 titled "Highly Purified Ethyl EPA and Other EPA Derivatives," also known as the EPA with no DHA in a capsule application. A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from an application.
"The issuance of a notice of allowance is a significant additional step forward in the execution of our plan to protect the commercial potential of AMR101," stated Joseph Zakrzewski, Chairman and Chief Executive Officer of Amarin. "Amarin's plan consists of continuing to pursue additional patent protection, seeking regulatory exclusivity, maintaining trade secrets and taking advantage of manufacturing barriers to entry, with the goal of protecting the commercial potential of AMR101 to 2030 and beyond. This patent application is one of Amarin's over 16 pending U.S. patent applications across over 11 patent families."
"The issuance of a notice of allowance is a significant additional step forward in the execution of our plan to protect the commercial potential of AMR101," stated Joseph Zakrzewski, Chairman and Chief Executive Officer of Amarin. "Amarin's plan consists of continuing to pursue additional patent protection, seeking regulatory exclusivity, maintaining trade secrets and taking advantage of manufacturing barriers to entry, with the goal of protecting the commercial potential of AMR101 to 2030 and beyond. This patent application is one of Amarin's over 16 pending U.S. patent applications across over 11 patent families."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reinstates Amarin Corporation (AMRN) at Underweight
- Cleveland-Cliffs plans $1B upgrade at Middletown Works steel plant
- Synaptics CFO resigns amid pending ON Semiconductor merger
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
